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Terpene synthases catalyse the first step in the conversion of
prenyl diphosphates to terpenoids. They act as templates for
their substrates to generate a reactive conformation, from
which a Mg2+-dependent reaction creates a carbocation–PPi
ion pair that undergoes a series of rearrangements and (de)-
protonations to give the final terpene product. This tight
conformational control was exploited for the (R)-germacrene A
synthase– and germacradien-4-ol synthase–catalysed formation
of a medium-sized cyclic terpenoid ether from substrates con-
taining nucleophilic functional groups. Farnesyl diphosphate
analogues with a 10,11-epoxide or an allylic alcohol were effi-
ciently converted to a 11-membered cyclic terpenoid ether
that was characterised by HRMS and NMR spectroscopic analy-
ses. Further experiments showed that other sesquiterpene syn-
thases, including aristolochene synthase, d-cadinene synthase
and amorphadiene synthase, yielded this novel terpenoid from
the same substrate analogues. This work illustrates the poten-
tial of terpene synthases for the efficient generation of struc-
turally and functionally novel medium-sized terpene ethers.
Terpenoids are the most diverse class of natural products and
possess astounding complexity in structure and biological
activity. They all arise from a small pool of isoprenoid diphos-
phate precursors. Amongst the tens of thousands of known
terpenoids are primary metabolites such as carotenoids and
ubiquinones as well as a large array of secondary metabolites
that act, for example, as semiochemicals, pheromones, antioxi-
dants, phytoalexins and cytotoxins.[1] The structural complexity
of these compounds presents a formidable challenge for
organic chemistry, and the synthetic generation of terpenoid
variants is often difficult. For example, most active analogues
of the antimalarial and anticancer drugs artemisinin[2] and pa-
clitaxel[3] only have modifications at the lactone group or the
amino acid side chain, as other changes are synthetically diffi-
cult to introduce. Moreover, terpene hydrocarbons are often
heat sensitive and unstable under acidic conditions, and their
chemical synthesis is cumbersome.[1] In the past, great efforts
have been made to overcome the challenging total syntheses
of such complex ring systems, but the synthesis of terpenoids
does not generally compete with direct extraction from natural
sources.[4] An alternative approach to the synthesis of terpene-
derived products exploits a detailed understanding of terpene
chemistry[5] and uses biotransformations to convert substrate
analogues to functionalised terpenoids.
Terpene synthases are divided into two classes depending
on the pathway used to form the initial carbocation. Class I
synthases use the Mg2+-binding motif to ionise the substrate
and form an allyl cation. In contrast, class II synthases form the
initial carbocation by protonation of the distal double bond or
an epoxide derivative thereof.[5a] Class I terpene synthases com-
prise a mostly hydrophobic active site, surrounded by an a-
helical barrel with two Mg2+-binding motifs at the entrance.[5a]
A large body of work on probing the chemical steps by using
substrate analogues,[6] mutagenesis,[7] putative reaction inter-
mediates[8] and X-ray crystallography[5a,9] combined with com-
putational approaches[5c, 10] has provided a detailed picture of
the mechanisms, by which these enzymes catalyse their reac-
tions.[5a,b] Co-crystal structures of aristolochene synthase with
various substrate analogues, Mg2+ and PPi,
[9c] in conjunction
with molecular modelling,[10a] revealed the detailed physical
steps that lead to the generation of the reactive Michaelis
complex. The synthase first binds one Mg2+ ion and then far-
nesyl diphosphate (FDP, 1) ; two more Mg2+ ions follow, and
this closes the active site, forming the Michaelis complex.[10a]
Coordination of the diphosphate by the Mg2+ ions triggers the
generation of a farnesyl cation (2) which is chaperoned by the
active-site contour through a series of electrophilic ring clo-
sures and rearrangements. Quenching of the final carbocation
either by proton loss or by nucleophilic capture generates the
terpenoid product.[5a,b] The active-site template steers this reac-
tion cascade, distinguishing it from many potentially compet-
ing, similar energy pathways with exquisite precision. After cat-
alysis of the initial C@O bond breakage, the role of the enzyme
in these chemical steps appears to be largely to act as a
template that steers the substrate through a series of reactive
conformations within an optimised electrostatic environ-
ment.[5b, c, 10b] The substrate adopts a specific conformation in
the active site that directs or inhibits site-selective nucleophilic
attack by solvent water.
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Harnessing the remarkable catalytic power of terpene syn-
thases to generate terpenoids and evolving them in a predicta-
ble and tunable manner can open the door to an expansion of
the terpenome. Exploring how terpene synthases control or in-
hibit the nucleophilic capture of carbocation intermediates has
recently become a focus of our research. We have explored
how native germacradien-4-ol synthase from Streptomyces citri-
color (GdolS) mediates the nucleophilic capture of the final car-
bocation by water and have converted a d-cadinene synthase
(DCS) from Gossypium arboreum into a GdolS by targeted site-
directed mutagenesis ; here a series of loop movements at the
active site allowed water ingress to capture the carbocation
rather than making use of a bound water molecule in the
closed form of the active site.[9b,11] Moreover, we have investi-
gated how FDP analogues containing nucleophilic functional
groups are converted by some sesquiterpene synthases; hence
12-OH-FDP was converted directly to dihydroartemisinic alde-
hyde by the amorphadiene synthase (ADS) from Artemisia
annua leading to the most concise artemisinin synthesis
known and demonstrating that hydroxylated FDPs can act as
efficient substrates for terpene synthases.[12] In the past, we
have used (S)-germacrene D synthase (GDS) and (R)-germacre-
ne A synthases (GAS; both from Solidago canadensis) to gener-
ate a pool of modified germacrenes[13] from a range of fluori-
nated and methylated FDP analogues. One of these products
is a potent attractant of grain aphids and a potential crop pro-
tection agent.[14] The efficiency of these transformations could
be improved dramatically by using segmented-flow meth-
ods.[13,15] Using the understanding of terpene synthase chemis-
try gained from this and others’ previous work, we surmised
that this could be done by introducing a nucleophile into a
substrate analogue to intercept a known carbocationic config-
uration generated through the templating effect of the
enzyme. A simple example to illustrate the proof of concept
would be to intercept the germacryl cation that is formed ini-
tially by 1,10-terpene cyclases (i.e. , those that catalyse an initial
1,10 ring closure of the FDP substrate, vide infra).
Herein, we describe the use of two 1,10-cyclases, namely
GdolS and GAS to synthesise an unnatural cyclic ether terpe-
noid from two synthetic oxygenated FDP analogues. The
former was chosen as an example of this chemoenzymatic in-
tramolecular capture as it is known naturally to use nucleophil-
ic quenching to capture the final carbocation during its catalyt-
ic cycle. The latter is a hydrocarbon synthase to exemplify that
this can also be done by both types of sesquiterpene synthase.
Both are mechanistically simple with no subsequent cyclisa-
tions of the 1,10-cyclisation product (Scheme 1) and hence
keep other potential active-site variables to a minimum. We
also show that several other sesquiterpene synthases are capa-
ble of converting these substrates to the same cyclic ether.
Allylic alcohol- and epoxide-containing FDP analogues 7 and
8 were chosen as suitable substrates for this investigation as it
was hypothesised that they would efficiently be converted to
cyclic ether 10 (Scheme 2). During GAS and GdolS catalysis
(Scheme 1), the initially formed farnesyl cation 2 is attacked by
the C10=C11 double bond to generate germacryl cation 3,[16]
so that the alcohol oxygen atom in 7 or the epoxide in 8
(Scheme 2) is ideally placed to intercept the carbocation in
intermediate 9 or 11, respectively. Proton loss from 9 would
then furnish cyclic ether 10. Similarly, cyclisation of epoxy
cation 11 should lead to carbocation 12. Deprotonation from
C12 of 12, as is seen with GAS,[17] should yield 10. Although
this was considered the most likely outcome, alternative prod-
ucts such as 13, 14, or 15 (Scheme 2) had to be ruled out
experimentally. Cleavage of the C10@O bond following nucleo-
philic attack at C1 with final proton loss would give the 12-
membered cyclic ether 15 ; alternatively, a [1,2]-methyl shift
from C11 followed by proton loss might result in 13 or 14.
Synthetic cDNAs for GAS and GdolS were overexpressed in
Escherichia coli. The resulting enzymes were purified as previ-
ously described[9b,18] and incubated on an analytical scale with
synthetically produced 7 and 8 (for synthetic details see Sec-
tion S2 in the Supporting Information). The pentane-extracta-
ble products were analysed by GC-MS (Figure 1 and Support-
Scheme 1. Reactions catalysed by GAS and GdolS with the natural substrate
1.
Scheme 2. Proposed reaction mechanism for the GAS- and GdolS-catalysed
conversions of 7 and 8 to the medium-sized terpene ether 10.
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ing Information). From the allylic alcohol 7, GdolS generated a
single product with a molecular ion of m/z 220 (Figures S1 and
S2). GAS produced the same product as only 50% of the pen-
tane-extractable products with the remaining 50% comprising
a mixture of unidentified products (Figure S3). Incubation of
epoxide 8 with GdolS and GAS also gave the same major com-
pound. However, a minor second product was formed by
GdolS (Figure 1). The major product for both enzymes showed
the same fragmentation pattern (Figures S4 and S5) in the
mass spectrum, and co-elution of all four product mixtures
confirmed an identical major product for each reaction (Fig-
ure S3). The major product was characterised as compound 10
(vide infra). The minor product (&10%) produced by GdolS
from 8 was identified by GC-MS as the epoxide derivative of
(E)-b-farnesene 16 after comparison with a sample generated
by conversion of 8 with (E)-b-farnesene synthase from Mentha
x piperita (EBFS; Figure 1).[19] As both analogues proved to be
substrates, other sesquiterpene synthases were tested. Aristo-
lochene synthase from Penicillium roqueforti produced com-
pound 10 as well as an unknown side product from both 7
and 8. On the other hand, DCS was only able to turn over 8 to
10, whereas ADS only accepted 7 to produce 10 (Figure S8). To
estimate the efficiency with which GdolS turned over 8, com-
petitive incubations of 8 and 1 with GdolS were performed
and analysed by GC-MS to follow the relative production of 6
and 10. Incubations of 3 mm enzyme with 0.125 mm 8 and
25 mm FDP led to similar turnovers of the two substrates. This
result suggests that turnover for the conversion of 8 by GdolS
is about 20% of that of the natural substrate 1. No conversion
was detected for any substrate in negative controls in which
enzyme was absent. Moreover, to demonstrate that this is a
specific templating effect of terpene synthases, 8 was incubat-
ed with alkaline phosphatase from bovine intestinal mucosa
(Sigma–Aldrich) as a positive control experiment. No formation
of any cyclised product was observed with only 10,11-epoxy
farnesol, that is, simple hydrolysis product was detected in the
pentane-extractable products only (Figures S9–S10).
To confirm the structure of the major product 10, a prepara-
tive-scale incubation of 8 with GdolS was performed. A colour-
less oil was isolated from the incubation of 60 mg of 8 (ESI) in
41% yield, which is a typical value for natural terpenoids pro-
duced from FDP in batch processes.[13] Unoptimised segment-
ed-flow procedures, which improve the extraction of the hy-
drophobic product from the aqueous phase, improved the
yield to 75%.[13,15] Both substrates (7 and 8) were prepared and
used in racemic form, and the products were analysed by GC
on a chiral stationary-phase and found to be a mixture of
enantiomers with a ratio of 48:52 (Figures S6 and S7). The
slight deviation from a racemate in the batch-generated prod-
uct arises from different conversion rates of the two enantio-
mers, as one might expect. This was reinforced when per-
formed in flow (Figure S11). The reaction in flow was per-
formed over 1 h, and a clearly faster turnover of one enantio-
mer occurred, whereas the batch incubation took several days
and led to loss of the initial enantioselectivity seen in flow.
Initial 1H NMR spectroscopic analysis of the batch product at
room temperature in CDCl3 showed broad, poorly defined sig-
nals in some areas of the spectrum; this hindered a full assign-
ment of the spectrum (Figure 2). Slow exchange on the NMR
timescale at room temperature has been observed previously
for similar medium-sized ring systems;[20] hence variable-tem-
perature NMR spectra were measured between @50 8C and
+50 8C. The structure was successfully elucidated at +50 8C.
Full assignments of the 1H and 13C NMR spectra are given in
the Table S1, they confirmed 10 as the major product generat-
ed by GdolS from 8.
At @50 8C, two conformations were apparent: for example,
the signal at dH=5.32 ppm, corresponding to the proton on
C2, split into two resonances at dH=5.19 and 5.48 ppm
(Figure 2) in an approximately 2:1 ratio. Resonances for the
minor conformation of 10 also appeared at @50 8C in all other
Figure 1. Top: Total ion chromatograms of the pentane-extractable products
from incubations of 8 with GAS (c), GdolS (c) and EBFS (c). Bottom.
Mass spectrum of the major product (10) eluting at 15.4 min.
Figure 2. 1H NMR spectra (400 MHz, CDCl3) of 10 at @50, +20 and +50 8C.
Inset : observed NOEs for 10.
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regions of the spectrum, particularly clearly for the protons on
C1 and C10 (dH=3.2–4.0 ppm) and in the alkyl region. A
NOESY spectrum at @50 8C showed several distinct NOEs
(Figure 2 and the Supporting Information), thus allowing some
conformational restraints to be applied. Close proximity was
apparent between the protons on C2 and C6, C13 and C15,
and C10 and C12. Hence, the major conformation of (R)-10 is
the down–down form, in which C14 and C15 are on the same
side of the ring system (Figure 3), with (S)-10 being the mirror
image. NOEs were not detectable for the minor isomer; how-
ever, the most significant changes in the 1H NMR spectrum, as
temperature decreased, corresponded to the protons on C1
and C2, thus suggesting that the minor conformer is the up–
down conformation (Figure 3), in which the methyl groups are
on opposite sides of the ten-membered ring. These two alkyl
groups change position most during the conformational transi-
tion.
The application of biologically active molecules is often de-
pendent on the availability of an efficient and economic syn-
thesis for their production. Terpene synthases can potentially
play key roles in the synthesis of blockbusting terpenoids and
are already employed in engineered fermentation platforms.[21]
However, such systems are still largely limited to the produc-
tion of natural terpenoids as they rely on the extended meta-
bolic pathways for FDP synthesis from simple primary metabo-
lites such as acetyl-CoA.[1a] The goal to develop biotechnologi-
cal platforms to generate novel oxygenated terpenoids in a
programmable and bespoke manner relies on a demonstration
that terpene synthases can generate novel products in vitro.
Although there are two examples in the literature in which un-
natural heterocycles have been generated by terpene synthas-
es,[22] and of course many examples of abortive products gen-
erated in mechanistic investigations of substrate analogues,[5–7]
our work shows for the first time that a novel terpenoid het-
erocycle can be generated by knowledge-based design and
conversion of a substrate analogue, thereby opening up the
use of terpene synthases to the preparation of complex chiral
organic compounds with potentially novel activities.
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